JP2023504048A5 - - Google Patents
Info
- Publication number
- JP2023504048A5 JP2023504048A5 JP2022530897A JP2022530897A JP2023504048A5 JP 2023504048 A5 JP2023504048 A5 JP 2023504048A5 JP 2022530897 A JP2022530897 A JP 2022530897A JP 2022530897 A JP2022530897 A JP 2022530897A JP 2023504048 A5 JP2023504048 A5 JP 2023504048A5
- Authority
- JP
- Japan
- Prior art keywords
- target
- circular guide
- artificial
- rna sequence
- guide rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962942725P | 2019-12-02 | 2019-12-02 | |
| US62/942,725 | 2019-12-02 | ||
| US202063112492P | 2020-11-11 | 2020-11-11 | |
| US63/112,492 | 2020-11-11 | ||
| PCT/US2020/062748 WO2021113264A1 (en) | 2019-12-02 | 2020-12-01 | Engineering circular guide rnas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504048A JP2023504048A (ja) | 2023-02-01 |
| JP2023504048A5 true JP2023504048A5 (cg-RX-API-DMAC7.html) | 2023-12-04 |
Family
ID=76221931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530897A Pending JP2023504048A (ja) | 2019-12-02 | 2020-12-01 | 環状ガイドrnaの遺伝子操作 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230036370A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4069830A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023504048A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115210366A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020395111A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3159799A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021113264A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3162908A1 (en) * | 2019-12-03 | 2021-06-10 | Beam Therapeutics Inc. | Synthetic guide rna, compositions, methods, and uses thereof |
| IL293671A (en) * | 2019-12-09 | 2022-08-01 | Astellas Pharma Inc | Antisense guide RNA with an additional functional region for target RNA editing |
| EP4158017A1 (en) * | 2020-05-26 | 2023-04-05 | Shape Therapeutics Inc. | Engineered circular polynucleotides |
| EP4240338A4 (en) * | 2021-01-04 | 2025-08-06 | Univ California | IN VIVO PROGRAMMABLE RNA EDITING BY RECRUITMENT OF ENDOGENOUS ADARS |
| JP2024504608A (ja) * | 2021-01-12 | 2024-02-01 | 北京大学 | 遺伝子操作rnaを使用した内因性adarの活用による標的化rnaの編集 |
| JP2024542983A (ja) * | 2021-10-26 | 2024-11-19 | シェイプ セラピューティクス インコーポレイテッド | Rna編集組成物及び使用方法 |
| EP4667570A1 (en) * | 2024-06-20 | 2025-12-24 | Johannes Gutenberg-Universität Mainz | Nucleic acid molecule complex for target pseudouridylation in mammalian cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150299702A1 (en) * | 2012-11-30 | 2015-10-22 | Aarhus Universitet | Circular rna for inhibition of microrna |
| CN106133138A (zh) * | 2013-08-22 | 2016-11-16 | 先锋国际良种公司 | 使用引导多核苷酸/cas内切核酸酶系统的基因组修饰及其使用方法 |
| AU2017283713B2 (en) * | 2016-06-17 | 2021-04-08 | Massachusetts Institute Of Technology | Type VI CRISPR orthologs and systems |
| WO2018237372A1 (en) * | 2017-06-23 | 2018-12-27 | Cornell University | RNA MOLECULES, METHODS FOR PRODUCING CIRCULAR RNA, AND METHODS OF TREATMENT |
| CN111328290A (zh) * | 2017-06-26 | 2020-06-23 | 博德研究所 | 用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法 |
| US20200362334A1 (en) * | 2017-12-07 | 2020-11-19 | The Broad Institute, Inc. | High-throughput methods for identifying gene interactions and networks |
| MX2020006150A (es) * | 2017-12-15 | 2020-11-11 | Flagship Pioneering Innovations Vi Llc | Composiciones que comprenden polirribonucleotidos circulares y usos de las mismas. |
| CN119193702A (zh) * | 2018-09-06 | 2024-12-27 | 加利福尼亚大学董事会 | 经由改造的adar募集的rna和dna碱基编辑 |
| AU2020313143B2 (en) * | 2019-07-12 | 2024-04-04 | Peking University | Targeted RNA editing by leveraging endogenous adar using engineered RNAs |
| EP4158017A1 (en) * | 2020-05-26 | 2023-04-05 | Shape Therapeutics Inc. | Engineered circular polynucleotides |
-
2020
- 2020-12-01 CA CA3159799A patent/CA3159799A1/en active Pending
- 2020-12-01 EP EP20895262.2A patent/EP4069830A4/en active Pending
- 2020-12-01 WO PCT/US2020/062748 patent/WO2021113264A1/en not_active Ceased
- 2020-12-01 US US17/781,686 patent/US20230036370A1/en active Pending
- 2020-12-01 CN CN202080094276.4A patent/CN115210366A/zh active Pending
- 2020-12-01 JP JP2022530897A patent/JP2023504048A/ja active Pending
- 2020-12-01 AU AU2020395111A patent/AU2020395111A1/en active Pending